IL17A and psoriasis: Second, to exclude the possibility that MCPIP3 regulates IL-17A response in a T-cell-intrinsic manner, we used an recombinant IL-23-induced psoriasis model, which sidesteps initial activation by myeloid cell and activates T cells directly via IL-2355.